KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Supernus Pharmaceuticals (SUPN) Non-Current Deferred Tax Liability (2019 - 2025)

Supernus Pharmaceuticals has reported Non-Current Deferred Tax Liability over the past 8 years, most recently at $981000.0 for Q1 2025.

  • Quarterly Non-Current Deferred Tax Liability fell 94.97% to $981000.0 in Q1 2025 from the year-ago period, while the trailing twelve-month figure was $981000.0 through Mar 2025, down 94.97% year-over-year, with the annual reading at $137.7 million for FY2024, 11.88% down from the prior year.
  • Non-Current Deferred Tax Liability was $981000.0 for Q1 2025 at Supernus Pharmaceuticals, down from $137.7 million in the prior quarter.
  • Over five years, Non-Current Deferred Tax Liability peaked at $229.6 million in Q4 2021 and troughed at $981000.0 in Q1 2025.
  • The 5-year median for Non-Current Deferred Tax Liability is $44.3 million (2023), against an average of $68.0 million.
  • Year-over-year, Non-Current Deferred Tax Liability soared 97.98% in 2022 and then tumbled 94.97% in 2025.
  • A 5-year view of Non-Current Deferred Tax Liability shows it stood at $229.6 million in 2021, then dropped by 19.58% to $184.7 million in 2022, then decreased by 15.39% to $156.3 million in 2023, then dropped by 11.88% to $137.7 million in 2024, then tumbled by 99.29% to $981000.0 in 2025.
  • Per Business Quant, the three most recent readings for SUPN's Non-Current Deferred Tax Liability are $981000.0 (Q1 2025), $137.7 million (Q4 2024), and $7.4 million (Q3 2024).